Ionis Pharmaceuticals Inc (IONS) Chairman & CEO Stanley T Crooke Sold $702,500 of Shares

Chairman & CEO of Ionis Pharmaceuticals Inc (30-Year Financial, Insider Trades) Stanley T Crooke (insider trades) sold 10,000 shares of IONS on 07/18/2019 at an average price of $70.25 a share. The total sale was $702,500.

Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases. Ionis Pharmaceuticals Inc has a market cap of $9.67 billion; its shares were traded at around $68.88 with a P/E ratio of 27.43 and P/S ratio of 12.75. GuruFocus has detected 2 severe warning signs with Ionis Pharmaceuticals Inc. .

CEO Recent Trades:

  • Chairman & CEO Stanley T Crooke sold 10,000 shares of IONS stock on 07/18/2019 at the average price of $70.25. The price of the stock has decreased by 1.95% since.

Directors and Officers Recent Trades:

  • COO Brett P Monia sold 210 shares of IONS stock on 07/02/2019 at the average price of $66.4. The price of the stock has increased by 3.73% since.
  • Director Spencer R Berthelsen sold 15,000 shares of IONS stock on 06/24/2019 at the average price of $63.67. The price of the stock has increased by 8.18% since.

For the complete insider trading history of IONS, click here

.